The effect of various types and doses of statins on C-reactive protein levels in patients with dyslipidemia or coronary heart disease: A systematic review and network meta-analysis
ObjectiveThe objective of this study was to measure the efficacy of various types and dosages of statins on C-reactive protein (CRP) levels in patients with dyslipidemia or coronary heart disease.MethodsRandomized controlled trials were searched from PubMed, Embase, Cochrane Library, OpenGray, and C...
Main Authors: | Jie Zhang, Xinyi Wang, Wende Tian, Tongxin Wang, Jundi Jia, Runmin Lai, Tong Wang, Zihao Zhang, Luxia Song, Jianqing Ju, Hao Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.936817/full |
Similar Items
-
Association between dietary inflammatory index and atherosclerosis cardiovascular disease in U.S. adults
by: Jie Zhang, et al.
Published: (2023-01-01) -
The combination use of inclisiran and statins versus statins alone in the treatment of dyslipidemia in mainland China: a cost-effectiveness analysis
by: Wenjing Zhou, et al.
Published: (2024-02-01) -
Factors Associated with Medication Non-Adherence in Patients with Dyslipidemia
by: Eman Alefishat, et al.
Published: (2021-06-01) -
An effect of statin on serum uric acid in patients with dyslipidemia at a tertiary care hospital
by: Anjan Palikhey, et al.
Published: (2023-12-01) -
Statins—Beyond Their Use in Hypercholesterolemia: Focus on the Pediatric Population
by: Elena Lia Spoiala, et al.
Published: (2024-01-01)